Related Experiment Video
Updated: Jun 28, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Genetic analysis of cancer-implicated MicroRNA in ovarian cancer
Jennifer L Bearfoot1, David Y H Choong, Kylie L Gorringe
1VBCRC Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Australia.
Purpose:
There is accumulating evidence that microRNAs may function like classic tumor suppressor genes but little is known about their mechanism of inactivation in cancer cells. We investigated whether somatic mutations are a common mechanism of inactivation of microRNA genes in ovarian cancer.
Experimental Design:
Ten cancer-implicated microRNA genes were analyzed for somatic mutations in 90 ovarian epithelial cancers and matching normal DNA. High-resolution melt analysis and bidirectional sequencing was used to detect sequence variations.
Results:
High-resolution melt analysis and direct sequencing did not identify any somatic mutations but did reveal numerous novel and previously reported germ line base substitutions, deletions, and insertions surrounding the mature microRNA sequences. The majority of variants were detected in the same proportion of non-cancer control individuals suggesting that they do not represent ovarian cancer-predisposing alleles.
Conclusion:
The absence of somatic mutations in any of the 10 cancer-implicated microRNAs in our large cohort of ovarian tumors suggests that this may be an uncommon mechanism of inactivation of microRNAs in ovarian cancer.
Insights
Somatic mutations do not appear to be a common way microRNA genes are inactivated in ovarian cancer. Researchers found no mutations in 10 cancer-related microRNAs across 90 ovarian tumors.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are increasingly recognized for their role in cancer, potentially acting as tumor suppressors.
- The specific mechanisms by which microRNA genes are inactivated in cancer cells remain largely unclear.
Purpose of the Study:
- To investigate whether somatic mutations are a frequent mechanism for inactivating microRNA genes in ovarian cancer.
- To analyze 10 specific microRNA genes implicated in cancer development.
Main Methods:
- Analysis of 10 cancer-implicated microRNA genes for somatic mutations in 90 ovarian epithelial cancers and matched normal DNA.
- Utilized high-resolution melt analysis and bidirectional sequencing to detect sequence variations.
Main Results:
- No somatic mutations were identified in the analyzed microRNA genes within the cohort of ovarian tumors.
- Numerous novel and known germline variations (substitutions, deletions, insertions) were found in regions flanking the mature microRNA sequences.
- The frequency of these germline variants in non-cancer controls suggests they are not ovarian cancer-predisposing alleles.
Conclusions:
- Somatic mutations appear to be an uncommon mechanism for microRNA gene inactivation in ovarian cancer.
- Germline variations, rather than somatic mutations, are frequently observed in the vicinity of these microRNA genes.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
